Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

CLS USA : Announces August Results with Significant Year-Over-Year Revenue Growth

09/22/2021 | 09:27am EST

LAS VEGAS, NV - CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the 'Company' or 'CLS', a diversified cannabis company operating as Cannabis Life Sciences, announced the financial and operational results for its Nevada wholly owned subsidiaries for the month of August 2021 with net revenues of $1.8M and a gross margin of 51.9%. These results represent a 24.8% year-over-year increase in monthly revenue, and a 50.7% increase in revenue when compared to August 2019. Overall August proved to be a great month as the retail side of the business, Oasis Cannabis was open for only 29 out of the month's 31 days. The closure was to reward the hardworking staff with a staff appreciation day and workshops for career advancement.

CLS Nevada August 2021 Financial and Operational Highlights

August 2021 net revenue increased by 24.8% year-over-year, and by 50.7% over August 2019. The Company met its gross margin goals, achieving 51.9% for the month, compared to 50.6% during August 2020.

The number of transactions processed at Oasis Cannabis increased 4.95% year-over-year increase with an average order value of $55.34 during August 2021.

The Company's branded division, City Trees, continued to gain market share and achieved a 90.9% increase in year-over-year revenue.

The Company continued to add jobs and benefits to the market, hiring a number of employees in August.

Oasis Cannabis was open for only 29 of the 31 days in August. The closure was a means to reward the staff with a staff appreciation day and workshops for career advancement.

'We continue to be amazed and in awe of our team on the ground in Nevada' noted Company President & COO Andrew Glashow. 'Their tireless effort and ability to adapt to market conditions have proven to be the strongest asset we have as we continue to grow. This was pivotal in helping us achieve our best August to date.'

About CLS Holdings USA, Inc.

CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for 'Cannabis Life Sciences,' in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. https://www.clsholdingsinc.com/.

Oasis Cannabis

Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named 'Best Dispensary for Pot Pros' by Desert Companion Magazine. In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products. http://oasiscannabis.com.

City Trees

Founded in 2017, City Trees is a Nevada-based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees products are available in numerous dispensaries throughout the state of Nevada. https://citytrees.com.

Forward-Looking Statements

This press release contains certain 'forward-looking information' within the meaning of applicable Canadian securities legislation and 'forward-looking statements' as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the 'forward-looking statements'). These statements relate to, among other things, the impact of the COVID-19 virus on our business, the results of our initiatives to retain our employees and strengthen our relationships with our customers and community during the pandemic, the effect of our initiatives to expand market share and achieve growth during and following the pandemic, results of operations and financial performance, anticipated future events, and the effectiveness of our business practices during the pandemic. The continued spread of COVID-19 could have, and in some cases already has had, an adverse impact on our business, operations and financial results, including through disruptions in our cultivation and processing activities, supply chains and sales channels, and retail dispensary operations as well as a deterioration of general economic conditions including a possible national or global recession. Due to the uncertainties associated with the continued spread of COVID-19 and the timing of vaccinations, it is not possible to estimate its impact on our business, operations or financial results; however, the impact could be material. In some cases, you can identify forward-looking statements by terminology such as 'may,' 'might,' 'will,' 'should,' 'intends,' 'expects,' 'plans,' 'goals,' 'projects,' 'anticipates,' 'believes,' 'estimates,' 'predicts,' 'potential,' or 'continue' or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at www.sedar.com for additional details.



Jeff Binder

Chairman and CEO

Andrew Glashow

President and COO

T: 888-438-9132


E: investors@clsholdingsinc.com

(C) 2021 Electronic News Publishing, source ENP Newswire

All news about CLS HOLDINGS USA, INC.
11/22CLS HOLDINGS USA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
10/26CLS HOLDINGS USA, INC. : Entry into a Material Definitive Agreement, Financial Statements ..
10/12A POSITIVE OUTLOOK : CLS Holdings USA, Inc. Reports Its First Ever Profitable Quarter with..
10/12CLS USA : Management's Discussion and Analysis of Financial Condition and Results of Opera..
10/12Cls Holdings Usa, Inc. Reports Earnings Results for the First Quarter Ended August 31, ..
09/29CLS HOLDINGS USA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
09/28CLS Holdings USA, Inc. Announces Joint Venture with Ranson Shepherd to Manufacture Pre-..
09/28CLS Holdings USA, Inc. Announces 50/50 Joint Venture with Ranson Shepherd to Manufactur..
09/22CLS USA : Announces August Results with Significant Year-Over-Year Revenue Growth
09/01CLS USA : Reports Record Fiscal Year End 2021 Results
More news
Financials (USD)
Sales 2021 19,3 M - -
Net income 2021 -15,9 M - -
Net Debt 2021 20,7 M - -
P/E ratio 2021 -1,35x
Yield 2021 -
Capitalization 15,4 M 15,4 M -
EV / Sales 2020 2,00x
EV / Sales 2021 2,22x
Nbr of Employees 2
Free-Float 62,7%
Duration : Period :
CLS Holdings USA, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Jeffrey I. Binder Chairman & Chief Executive Officer
Andrew J. Glashow President, COO, Chief Financial Officer & Director
Ross Silver Director
Matthew Janz Vice President-Marketing
Sector and Competitors
1st jan.Capi. (M$)
ROKU, INC.-38.09%27 618
BOLLORÉ SE38.02%15 311
VIVENDI SE-57.39%13 319